Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Archives of Pediatric Infectious DiseasesOpen Access

The Efficacy of Nebulized 3% Hypertonic Saline for Acute Bronchiolitis in Infants: A Randomized Controlled Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

NCNgo Quy ChauQLQui Phu LaSLSon Hoang Le

Discussion

Loading...

Member takes

Overview

Randomized controlled trial shows nebulized hypertonic saline improves clinical outcomes in infants with acute bronchiolitis, indicating its potential as a safe treatment.

Key Points

  • Nebulized 3% hypertonic saline significantly reduced clinical severity scores in infants with acute bronchiolitis.
  • The treatment group showed a median length of hospital stay of 5 days, compared to 7 days for the control group.
  • Improvements in respiratory distress assessment instrument scores were also notable in the treatment group.
  • No adverse effects were reported for nebulized 3% hypertonic saline during the trial.

Cite This Study

Chau et al. (2025) studied this question.

synapsesocial.com/papers/68c23fc3b210217d647977cahttps://doi.org/10.5812/apid-158410
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A comparative study of nebulized 3% hypertonic saline and normal saline in the management of respiratory syncytial virus-positive acute bronchiolitis in young infants2025
  2. 2Efficacy of Hypertonic Saline vs Normal Saline + Salbutamol in Treating Acute Bronchiolitis in a Tertiary Care Hospital2025
  3. 3Comparison of Hypertonic Saline with Normal Saline Nebulization in the Management of Bronchiolitis in Children2025
  4. 4Comparison of Mean Length of Hospital Stay in Children with Bronchiolitis Nebulized with 3% Hypertonic Saline with versus without Epinephrine2024
  5. 5A study on the effectiveness of various treatment approaches for bronchiolitis2025